← Brewed Up Insight No. 66

NPPA's cap would save ₹2,500 crore of ₹10,250 crore

What India spends each year on cancer drugs with no price limit. NPPA expects its cap to save about a quarter of it.

NPPA's cap would save ₹2,500 crore of ₹10,250 crore

What India spends each year on cancer drugs with no price limit. NPPA expects its cap to save about a quarter of it.

₹ CRORE A YEAR

  • Saved by the cap2,500 24.4%
  • Still spent7,750 75.6%
Bar of the ₹10,250 crore India spends each year on cancer drugs with no price limit: ₹2,500 crore, 24.4%, saved by NPPA's proposed cap, and ₹7,750 crore, 75.6%, still spent. Another ₹2,250 crore of cancer drugs already has a price limit. The saving depends on which drugs an expert committee lists, due 14 October 2026.

Another ₹2,250 crore of cancer drugs already has a price limit. The saving depends on which drugs an expert committee lists, due 14 October 2026.

NPPA, minutes of the 151st Authority meeting, 8 October 2026 · Oct 2026

Share it

The numbers

Embed it on your site

The code carries a credit line that links back to this page. Keep it with the chart.

Get in touch